Tandem BreastfeedingNCT05338203
Comparison of Breast Milk Contents in Tandem Breastfeeding and Non-Tandem Breastfeeding Mother
A study testing tandem breastfeedıng in people with Tandem Breastfeeding, run by Gazi University at 1 site in Turkey (Türkiye).
Trial summary
Breastfeeding is the gold standard for feeding newborns and infants. Tandem breastfeeding is defined as breastfeeding during pregnancy or simultaneous breastfeeding of two non-twins. Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Tandem Breastfeeding
- What is being tested?
- tandem breastfeedıng
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Apr 2022to 30 May 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- If pregnant, being in the second trimester of pregnancy; have given birth, postpartum 16th day or more
- If pregnant, not having a risky pregnancy
- If she is pregnant, there is a report from the obstetrician she is followed that there is no harm in breastfeeding
- The older child being breastfed is under the age of 2
- Absence of literacy problems, mental disabilities and communication problems
- Absence of chronic disease
Show all 20Show fewer
- No communicable disease
- Not using a drug continuously
- Not using any medication in the last 24 hours
- Willingness to participate in the study
- Postpartum 16th day and above
- No risky pregnancy in her last pregnancy
- Being multiparous
- Absence of literacy problems, mental disabilities and communication problems
- Absence of chronic disease
- No communicable disease
- Not using a drug continuously
- Not using any medication in the last 24 hours
- Willingness to participate in the study
- Exclusion criteria. During the research process, mothers will be excluded from the sample in case the mothers want to leave the study, the sample milk is spoiled or there are losses during the analysis.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Sıdıka PELİT AKSU
Ankara, Turkey/Ankara, 06500
About this study
Breastfeeding is the gold standard for feeding newborns and infants. Tandem breastfeeding is defined as breastfeeding during pregnancy or simultaneous breastfeeding of two non-twins. The aim of this study; The aim of this study is to compare breast milk contents of mothers who breastfeed in tandem and mothers who do not breastfeed in tandem. The study was planned as an experimental study with a single center control group. The place where the research will be conducted is the Lactation/Relactation outpatient clinic and gynecology and obstetrics polyclinic of Çamlıca Medipol University Hospital and Halil Şıvgın Çubuk State Hospital. and tandem non-breastfeeding mothers. Power analysis was performed to determine the number of samples. For this purpose, the study results of Rosenberg et al. (2021) (Experiment: 8.1±0.2 Control:6.2±1.5) were used as reference. According to the power analysis made by calculating the effect size, the sample size calculated with α= 0.01 error level and 99% power; 18 women in the experimental group and 18 women in the control group, a total of at least 36 women. The analysis was made in G*Power version 3.1.9.4. All mothers will be informed about the study, and mothers who accept the study will have to fill out the "Conformity to Criteria Form" created by the researchers. Written informed consent will be obtained from mothers who meet the research criteria. After completing the introductory information form, milk will be collected from all mothers. Milk collection will be done by one of the researchers. Milking will always be collected from all mothers between 08:00 and 16:00, provided that at least 40 minutes have passed after the last milking. Manual milking will be done for 10 minutes.
Read the detailed description
There are studies on the concentration of macronutrients in breast milk in the literature A few studies have examined macronutrients in breast milk in mothers who breastfeed in tandem. Sinkiewicz-Darol et al. (2021) in his study; Macronutrients in breast milk in mothers who breastfeed in tandem have been studied. Breast milk during tandem breastfeeding had higher fat content, energy value, and total protein concentration than milk after weaning the older child. The carbohydrate content remained constant. In the study of Rosenberg et al., (2021), the concentration of macronutrients in breast milk was investigated in tandem breastfeeding and non-tandem breastfeeding mothers. As a result, it was determined that breast milk produced during pregnancy has different macronutrient content than breast milk produced after birth. It was determined that colostrum and mature milk of mothers who breastfed in tandem were similar to the milk of mothers who did not breastfeed in tandem, except for the carbohydrate content. Breastfeeding and tandem breastfeeding during pregnancy have not been extensively studied. For this reason, our study will determine the effect of tandem breastfeeding on the macronutrient content of breast milk and will provide evidence for tandem breastfeeding, which is traditionally practiced by many women.
1.2 Purpose of Research The aim of this study; The aim of this study is to compare the breast milk contents of tandem breastfeeding and non-tandem breastfeeding mothers.
- METHODS and MATERIALS 2.1. Type of Research The research was planned as an experimental study with a single center control group.
2.2. Place of Research The place where the research will be carried out is the Lactation/Relactation polyclinic and gynecology and obstetrics polyclinic of Çamlıca Medipol University Hospital and Halil Şıvgın Çubuk State Hospital.
2.3. Sample of the Research The population of the study will be tandem breastfeeding and non-tandem breastfeeding mothers who applied to the Lactation/Relactation outpatient clinic of Çamlıca Medipol University Hospital and Halil Şıvgın Çubuk State Hospital, and the obstetrics and gynecology outpatient clinics. Power analysis was performed to determine the number of samples. For this purpose, the study results of Rosenberg et al. (2021) (Experiment: 8.1±0.2 Control:6.2±1.5) were used as reference. According to the power analysis made by calculating the effect size, the sample size calculated with α= 0.01 error level and 99% power; 18 women in the experimental group and 18 women in the control group, a total of at least 36 women. The analysis was performed in G*Power version 3.1.9.4.
2.3.3. Example Selection Criteria All women who meet the following criteria will be invited to participate in the study.
Experiment:
- If pregnant, being in the second trimester of pregnancy; have given birth, postpartum 16th day or more
- If pregnant, not having a risky pregnancy
- If she is pregnant, there is a report from the obstetrician she is followed that there is no harm in breastfeeding
- The older child being breastfed is under the age of 2
- Absence of literacy problems, mental disabilities and communication problems
- Absence of chronic disease
- No communicable disease
- Not using a drug continuously
- Not using any medication in the last 24 hours
- Willingness to participate in the study
Control:
- Postpartum 16th day and above
- No risky pregnancy in her last pregnancy
- Being multiparous
- Absence of literacy problems, mental disabilities and communication problems
- Absence of chronic disease
- No communicable disease
- Not using a drug continuously
- Not using any medication in the last 24 hours
- Willingness to participate in the study During the research process, mothers will be excluded from the sample in case the mothers want to leave the study, the sample milk is spoiled or there are losses during the analysis.
2.3.4. Randomization Randomization will not be possible in the study. 2.4. Data Collection All mothers will be informed about the study, and mothers who accept the study will have to fill out the "Conformity to Criteria Form" created by the researchers. Written informed consent will be obtained from mothers who meet the research criteria. After completing the introductory information form, milk will be collected from all mothers.
Collection of breast milk Milk collection will be done by one of the researchers. Milking will always be collected from all mothers between 08:00 and 16:00, provided that at least 40 minutes have passed after the last milking. Manual milking will be done for 10 minutes.
Collected breast milk samples will be frozen at -180C within two hours. It will be allowed to dissolve by keeping it at +40C 48 hours before the analysis. Breast milk samples, which are heated up to 400C in a water bath, will be homogenized by Miris Ultrasonic Homogenizer for 5 seconds just before analysis. Breast milk samples will be analyzed with Miris®️ HMA, and protein, fat, carbohydrate and energy values will be determined. Miris®️ HMA (Uppsala, Sweden) is certified by the International Standards Organization (ISO) 9622: 1999. The device, which has different filters for special milk components, uses four different wavebands for fat, protein and lactose determination. Miris®️ HMA device consists of a cuvette and auxiliary equipment. The so-called cuvette is a mid-infrared measuring cell with an inlet and an outlet. Breast milk is injected through the vestibule, passing through two CaF2 windows divided by a spacer (50 μm). On one side of the windows is a source of infrared radiation (emitter) and on the other side there is a four-channel detector that receives the radiation transmitted through the liquid. The filters in the detector are chosen to absorb mid-infrared radiation associated with fat, protein and carbohydrate. The fourth filter acts as a reference filter. Radiation from the infrared source passes through the Transparent cuvette with the liquid sample, assessing the amounts of radiation absorbed by specific functional groups of fat, protein and carbohydrate, respectively. The quantitative determination of fat, protein and carbohydrate absorbed in direct proportion to the concentration is made according to Beer's law. Each macronutrient composition is calculated by Miris®️ HMA in g per 100 ml. Fat molecules are determined by ester bonds to the carbonyl groups of glycerides, and protein molecules are determined by the infrared method with the second amide group of peptide bonds. The lactose content is analyzed by lactose and hydroxyl groups of mono/oligosaccharides, and the total energy is determined by calculating the measurement results. The pH measurement will be measured with the MW102, Milwaukee® instrument.
2.4.1. Data Collection Tools 'Conformity to Criteria Form' (Appendix-1), Introductory Information Form (Appendix-2) and 'Breast Milk Biochemical Analysis Form' (Appendix-3) will be used in collecting research data.
2.4.1.1. Conformity to Criteria Form (Annex-1) This form includes a checklist of inclusion criteria. 2.4.1.2. Introductory Information Form (Appendix -2) This form, which was developed by the researcher using the literature, has 5, which determines the socio-demographic characteristics of mothers (age, education level, income level, occupation), 6 that determines their obstetric characteristics (number of pregnancy, gestational week, birth), and 1 is about the baby and breastfeeding, a total of 12 forms. consists of questions.
2.4.1.3. Breast Milk Biochemical Analysis Form (Appendix-3) Developed by researchers. In the evaluation of breast milk content, Ph, fat, carbohydrate, protein and energy values, which are possible to change with the milking method, will be written on the form according to the results of the analysis.
2.5. Evaluation of Data The data obtained in the research will be evaluated with the SPSS (Statistical Package of Social Sciences) 22.0 package program. The homogeneity of the variances in both groups will be checked with the Levene test, and the normality with the Shaphiro Wilk test. If the variances are homogeneous and normally distributed, T-test will be used for independent groups from parametric tests, and if the variances are not homogeneous and do not show normal distribution, the Mann Whitney-U test will be used. 0.05 will be used as the level of significance and it will be stated that there is a significant relationship in case of p<0.05, and that there is no significant relationship in the case of p>0.05. In order to determine the effect of mediator variables on breast milk, mediator and moderator variable analyzes will be performed.
2.6. Ethical Aspect of Research The application will be started after the necessary permissions from the institution where the research will be conducted, the ethics committee and written consent from the mothers are obtained. Mothers can opt out of the study whenever they want. No payment will be made to mothers for participating in the study.
- Conditions
- Tandem Breastfeeding
- Being tested
- tandem breastfeedıng
- Keywords
- mother milk, Breastfeeding, tandem
- Medical subject headings
- Breast Feeding
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
tandem breastfeedıngOther
mother mılk wıll collected from mothers and they wıll be analyzed in laboratuar.
| Study group | Role | What they receive |
|---|---|---|
| experimental group (tandem breastfeeding) | Experimental | mother mılk wıll collected from these mother and they wıll be analyzed Receives: Other: tandem breastfeedıng |
| control group ( non-tandem breastfeeding) | No intervention | mother mılk wıll collected from these mother and they wıll be analyzed |
What is being measured
The primary outcome is the main question the study is designed to answer.
change in protein levels
ıt wıll be analyzed from mılk
Measured: 15 days
Secondary outcomes (4)
change in ph levels
ıt wıll be analyzed from mılk
Measured: 15 days
change in carbonhidrad levels
ıt wıll be analyzed from mılk
Measured: 15 days
change in energy levels
ıt wıll be analyzed from mılk
Measured: 15 days
change in fat levels
ıt wıll be analyzed from mılk
Measured: 15 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Apr 2022
- Study start15 Apr 2022 (estimated)
- Primary completion15 May 2022 (estimated)
- Study completion30 May 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Tandem BreastfeedingStudies of the same condition, open and under way.
- More trials run by Gazi UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Gazi University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sidika Pelit Aksu, Gazi University
- Investigators
- Sıdıka PELİT AKSU, PhD, Principal investigator, Gazi University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05338203
- Sponsor's protocol ID
- 10840098
- Status last verified
- Apr 2022
- First submitted
- 30 Mar 2022
- Last updated
- 21 Apr 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Apr 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Breast Milk Contents in Tandem Breastfeeding and Non-Tandem Breastfeeding Mother
- ClinicalTrials.gov ID
- NCT05338203
- Acronym / sponsor ID
- 10840098
- Conditions
- Tandem Breastfeeding
- Keywords
- mother milk, Breastfeeding, tandem
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- Gazi UniversityUniversity, hospital or other
- Study start
- 15 Apr 2022 (estimated)
- Primary completion
- 15 May 2022 (estimated)
- Study completion
- 30 May 2022 (estimated)
- First posted
- 21 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Breastfeeding is the gold standard for feeding newborns and infants. Tandem breastfeeding is defined as breastfeeding during pregnancy or simultaneous breastfeeding of two non-twins. The aim of this study; The aim of this study is to compare breast milk contents of mothers who breastfeed in tandem and mothers who do not breastfeed in tandem. The study was planned as an experimental study with a single center control group. The place where the research will be conducted is the Lactation/Relactation outpatient clinic and gynecology and obstetrics polyclinic of Çamlıca Medipol University Hospital and Halil Şıvgın Çubuk State Hospital. and tandem non-breastfeeding mothers. Power analysis was performed to determine the number of samples. For this purpose, the study results of Rosenberg et al. (2021) (Experiment: 8.1±0.2 Control:6.2±1.5) were used as reference. According to the power analysis made by calculating the effect size, the sample size calculated with α= 0.01 error level and 99% power; 18 women in the experimental group and 18 women in the control group, a total of at least 36 women. The analysis was made in G*Power version 3.1.9.4. All mothers will be informed about the study, and mothers who accept the study will have to fill out the "Conformity to Criteria Form" created by the researchers. Written informed consent will be obtained from mothers who meet the research criteria. After completing the introductory information form, milk will be collected from all mothers. Milk collection will be done by one of the researchers. Milking will always be collected from all mothers between 08:00 and 16:00, provided that at least 40 minutes have passed after the last milking. Manual milking will be done for 10 minutes.
Detailed description
There are studies on the concentration of macronutrients in breast milk in the literature A few studies have examined macronutrients in breast milk in mothers who breastfeed in tandem. Sinkiewicz-Darol et al. (2021) in his study; Macronutrients in breast milk in mothers who breastfeed in tandem have been studied. Breast milk during tandem breastfeeding had higher fat content, energy value, and total protein concentration than milk after weaning the older child. The carbohydrate content remained constant. In the study of Rosenberg et al., (2021), the concentration of macronutrients in breast milk was investigated in tandem breastfeeding and non-tandem breastfeeding mothers. As a result, it was determined that breast milk produced during pregnancy has different macronutrient content than breast milk produced after birth. It was determined that colostrum and mature milk of mothers who breastfed in tandem were similar to the milk of mothers who did not breastfeed in tandem, except for the carbohydrate content. Breastfeeding and tandem breastfeeding during pregnancy have not been extensively studied. For this reason, our study will determine the effect of tandem breastfeeding on the macronutrient content of breast milk and will provide evidence for tandem breastfeeding, which is traditionally practiced by many women.
1.2 Purpose of Research The aim of this study; The aim of this study is to compare the breast milk contents of tandem breastfeeding and non-tandem breastfeeding mothers.
- METHODS and MATERIALS 2.1. Type of Research The research was planned as an experimental study with a single center control group.
2.2. Place of Research The place where the research will be carried out is the Lactation/Relactation polyclinic and gynecology and obstetrics polyclinic of Çamlıca Medipol University Hospital and Halil Şıvgın Çubuk State Hospital.
2.3. Sample of the Research The population of the study will be tandem breastfeeding and non-tandem breastfeeding mothers who applied to the Lactation/Relactation outpatient clinic of Çamlıca Medipol University Hospital and Halil Şıvgın Çubuk State Hospital, and the obstetrics and gynecology outpatient clinics. Power analysis was performed to determine the number of samples. For this purpose, the study results of Rosenberg et al. (2021) (Experiment: 8.1±0.2 Control:6.2±1.5) were used as reference. According to the power analysis made by calculating the effect size, the sample size calculated with α= 0.01 error level and 99% power; 18 women in the experimental group and 18 women in the control group, a total of at least 36 women. The analysis was performed in G*Power version 3.1.9.4.
2.3.3. Example Selection Criteria All women who meet the following criteria will be invited to participate in the study.
Experiment:
- If pregnant, being in the second trimester of pregnancy; have given birth, postpartum 16th day or more
- If pregnant, not having a risky pregnancy
- If she is pregnant, there is a report from the obstetrician she is followed that there is no harm in breastfeeding
- The older child being breastfed is under the age of 2
- Absence of literacy problems, mental disabilities and communication problems
- Absence of chronic disease
- No communicable disease
- Not using a drug continuously
- Not using any medication in the last 24 hours
- Willingness to participate in the study
Control:
- Postpartum 16th day and above
- No risky pregnancy in her last pregnancy
- Being multiparous
- Absence of literacy problems, mental disabilities and communication problems
- Absence of chronic disease
- No communicable disease
- Not using a drug continuously
- Not using any medication in the last 24 hours
- Willingness to participate in the study During the research process, mothers will be excluded from the sample in case the mothers want to leave the study, the sample milk is spoiled or there are losses during the analysis.
2.3.4. Randomization Randomization will not be possible in the study. 2.4. Data Collection All mothers will be informed about the study, and mothers who accept the study will have to fill out the "Conformity to Criteria Form" created by the researchers. Written informed consent will be obtained from mothers who meet the research criteria. After completing the introductory information form, milk will be collected from all mothers.
Collection of breast milk Milk collection will be done by one of the researchers. Milking will always be collected from all mothers between 08:00 and 16:00, provided that at least 40 minutes have passed after the last milking. Manual milking will be done for 10 minutes.
Collected breast milk samples will be frozen at -180C within two hours. It will be allowed to dissolve by keeping it at +40C 48 hours before the analysis. Breast milk samples, which are heated up to 400C in a water bath, will be homogenized by Miris Ultrasonic Homogenizer for 5 seconds just before analysis. Breast milk samples will be analyzed with Miris®️ HMA, and protein, fat, carbohydrate and energy values will be determined. Miris®️ HMA (Uppsala, Sweden) is certified by the International Standards Organization (ISO) 9622: 1999. The device, which has different filters for special milk components, uses four different wavebands for fat, protein and lactose determination. Miris®️ HMA device consists of a cuvette and auxiliary equipment. The so-called cuvette is a mid-infrared measuring cell with an inlet and an outlet. Breast milk is injected through the vestibule, passing through two CaF2 windows divided by a spacer (50 μm). On one side of the windows is a source of infrared radiation (emitter) and on the other side there is a four-channel detector that receives the radiation transmitted through the liquid. The filters in the detector are chosen to absorb mid-infrared radiation associated with fat, protein and carbohydrate. The fourth filter acts as a reference filter. Radiation from the infrared source passes through the Transparent cuvette with the liquid sample, assessing the amounts of radiation absorbed by specific functional groups of fat, protein and carbohydrate, respectively. The quantitative determination of fat, protein and carbohydrate absorbed in direct proportion to the concentration is made according to Beer's law. Each macronutrient composition is calculated by Miris®️ HMA in g per 100 ml. Fat molecules are determined by ester bonds to the carbonyl groups of glycerides, and protein molecules are determined by the infrared method with the second amide group of peptide bonds. The lactose content is analyzed by lactose and hydroxyl groups of mono/oligosaccharides, and the total energy is determined by calculating the measurement results. The pH measurement will be measured with the MW102, Milwaukee® instrument.
2.4.1. Data Collection Tools 'Conformity to Criteria Form' (Appendix-1), Introductory Information Form (Appendix-2) and 'Breast Milk Biochemical Analysis Form' (Appendix-3) will be used in collecting research data.
2.4.1.1. Conformity to Criteria Form (Annex-1) This form includes a checklist of inclusion criteria. 2.4.1.2. Introductory Information Form (Appendix -2) This form, which was developed by the researcher using the literature, has 5, which determines the socio-demographic characteristics of mothers (age, education level, income level, occupation), 6 that determines their obstetric characteristics (number of pregnancy, gestational week, birth), and 1 is about the baby and breastfeeding, a total of 12 forms. consists of questions.
2.4.1.3. Breast Milk Biochemical Analysis Form (Appendix-3) Developed by researchers. In the evaluation of breast milk content, Ph, fat, carbohydrate, protein and energy values, which are possible to change with the milking method, will be written on the form according to the results of the analysis.
2.5. Evaluation of Data The data obtained in the research will be evaluated with the SPSS (Statistical Package of Social Sciences) 22.0 package program. The homogeneity of the variances in both groups will be checked with the Levene test, and the normality with the Shaphiro Wilk test. If the variances are homogeneous and normally distributed, T-test will be used for independent groups from parametric tests, and if the variances are not homogeneous and do not show normal distribution, the Mann Whitney-U test will be used. 0.05 will be used as the level of significance and it will be stated that there is a significant relationship in case of p<0.05, and that there is no significant relationship in the case of p>0.05. In order to determine the effect of mediator variables on breast milk, mediator and moderator variable analyzes will be performed.
2.6. Ethical Aspect of Research The application will be started after the necessary permissions from the institution where the research will be conducted, the ethics committee and written consent from the mothers are obtained. Mothers can opt out of the study whenever they want. No payment will be made to mothers for participating in the study.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| experimental group (tandem breastfeeding) | Experimental | Other: tandem breastfeedıngmother mılk wıll collected from these mother and they wıll be analyzed |
| control group ( non-tandem breastfeeding) | No intervention | –mother mılk wıll collected from these mother and they wıll be analyzed |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (20 listed)
- If pregnant, being in the second trimester of pregnancy; have given birth, postpartum 16th day or more
- If pregnant, not having a risky pregnancy
- If she is pregnant, there is a report from the obstetrician she is followed that there is no harm in breastfeeding
- The older child being breastfed is under the age of 2
- Absence of literacy problems, mental disabilities and communication problems
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| tandem breastfeedıngmother mılk wıll collected from mothers and they wıll be analyzed in laboratuar. | Other | experimental group (tandem breastfeeding) |
Primary outcome
change in protein levels
Time frame: 15 days
ıt wıll be analyzed from mılk
4 secondary outcomes
change in ph levels
Time frame: 15 days
change in carbonhidrad levels
Time frame: 15 days
change in energy levels
Time frame: 15 days
change in fat levels
Time frame: 15 days
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Apr 2022.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sıdıka PELİT AKSU, PhD principal investigator
Gazi University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing tandem breastfeedıng in people with Tandem Breastfeeding, run by Gazi University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 20 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 21 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Sıdıka PELİT AKSU, PhD (+905069583180, sidikapelit@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
change in protein levels (time frame: 15 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Apr 2022.